Downloads: 363

Files in This Item:
File Description SizeFormat 
scitranslmed.aaj2300.pdf5.65 MBAdobe PDFView/Open
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHitomi, Hirofumija
dc.contributor.authorKasahara, Tomokoja
dc.contributor.authorKatagiri, Naokoja
dc.contributor.authorHoshina, Azusaja
dc.contributor.authorMae, Shin-Ichija
dc.contributor.authorKotaka, Makija
dc.contributor.authorToyohara, Takafumija
dc.contributor.authorRahman, Asadurja
dc.contributor.authorNakano, Daisukeja
dc.contributor.authorNiwa, Akiraja
dc.contributor.authorSaito, Megumu K.ja
dc.contributor.authorNakahata, Tatsutoshija
dc.contributor.authorNishiyama, Akiraja
dc.contributor.authorOsafune, Kenjija
dc.contributor.alternative人見, 浩史ja
dc.contributor.alternative西山, 成ja
dc.contributor.alternative長船, 健二ja
dc.date.accessioned2017-10-05T04:57:45Z-
dc.date.available2017-10-05T04:57:45Z-
dc.date.issued2017-09-27ja
dc.identifier.issn1946-6234ja
dc.identifier.urihttp://hdl.handle.net/2433/227425-
dc.descriptionヒトiPS/ES細胞からエリスロポエチン産生細胞の作製に成功 --腎性貧血に対する細胞療法の可能性--. 京都大学プレスリリース. 2017-09-28.ja
dc.descriptionTitle of the accepted manuscript is 'Human pluripotent stem cell-derived erythropoietin-producing cells improve renal anemia in mice'.ja
dc.description.abstractThe production of erythropoietin (EPO) by the kidneys, a principal hormone for the hematopoietic system, is reduced in patients with chronic kidney disease (CKD), eventually resulting in severe anemia. Although recombinant human EPO treatment improves anemia in patients with CKD, returning to full red blood cell production without fluctuations does not always occur. We established a method to generate EPO-producing cells from human induced pluripotent stem cells (hiPSCs) by modifying previously reported hepatic differentiation protocols. These cells showed increased EPO expression and secretion in response to low oxygen conditions, prolyl hydroxylase domain–containing enzyme inhibitors, and insulin-like growth factor 1. The EPO protein secreted from hiPSC-derived EPO-producing (hiPSC-EPO) cells induced the erythropoietic differentiation of human umbilical cord blood progenitor cells in vitro. Furthermore, transplantation of hiPSC-EPO cells into mice with CKD induced by adenine treatment improved renal anemia. Thus, hiPSC-EPO cells may be a useful tool for clarifying the mechanisms of EPO production and may be useful as a therapeutic strategy for treating renal anemia.ja
dc.format.mimetypeapplication/pdf-
dc.language.isoengja
dc.publisherAmerican Association for the Advancement of Science (AAAS)ja
dc.rightsThis is the author's version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in 'Science Translational Medicine' on Vol. 9, Issue 409, eaaj2300, DOI: 10.1126/scitranslmed.aaj2300ja
dc.rightsThis is not the published version. Please cite only the published version. この論文は出版社版でありません。引用の際には出版社版をご確認ご利用ください。ja
dc.titleHuman pluripotent stem cell–derived erythropoietin-producing cells ameliorate renal anemia in miceja
dc.title.alternativeHuman pluripotent stem cell-derived erythropoietin-producing cells improve renal anemia in miceja
dc.type.niitypeJournal Articleja
dc.identifier.jtitleScience Translational Medicineja
dc.identifier.volume9ja
dc.identifier.issue409ja
dc.relation.doi10.1126/scitranslmed.aaj2300ja
dc.textversionauthorja
dc.identifier.artnumeaaj2300ja
dc.identifier.pmid28954928ja
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2017-09-28ja
Appears in Collections:Journal Articles

Show simple item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.